Intuitive Surgical Company Profile (NASDAQ:ISRG)

About Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical logoIntuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company's instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ISRG
  • CUSIP: 46120E60
  • Web:
  • Market Cap: $35.79927 billion
  • Outstanding Shares: 36,840,000
Average Prices:
  • 50 Day Moving Avg: $934.93
  • 200 Day Moving Avg: $803.42
  • 52 Week Range: $610.71 - $974.66
  • Trailing P/E Ratio: 46.75
  • Foreward P/E Ratio: 39.20
  • P/E Growth: 3.72
Sales & Book Value:
  • Annual Revenue: $2.78 billion
  • Price / Sales: 12.29
  • Book Value: $112.16 per share
  • Price / Book: 8.27
  • EBIDTA: $1.08 billion
  • Net Margins: 28.44%
  • Return on Equity: 15.51%
  • Return on Assets: 13.71%
  • Current Ratio: 3.88%
  • Quick Ratio: 3.50%
  • Average Volume: 325,924 shs.
  • Beta: 0.39
  • Short Ratio: 8.44

Frequently Asked Questions for Intuitive Surgical (NASDAQ:ISRG)

What is Intuitive Surgical's stock symbol?

Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."

How were Intuitive Surgical's earnings last quarter?

Intuitive Surgical, Inc. (NASDAQ:ISRG) posted its earnings results on Thursday, July, 20th. The company reported $5.95 EPS for the quarter, beating the consensus estimate of $5.79 by $0.16. The firm earned $756.20 million during the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a return on equity of 15.51% and a net margin of 28.44%. The business's quarterly revenue was up 12.8% on a year-over-year basis. During the same period last year, the company earned $5.62 earnings per share. View Intuitive Surgical's Earnings History.

When will Intuitive Surgical make its next earnings announcement?

Intuitive Surgical is scheduled to release their next quarterly earnings announcement on Monday, October, 16th 2017. View Earnings Estimates for Intuitive Surgical.

Where is Intuitive Surgical's stock going? Where will Intuitive Surgical's stock price be in 2017?

17 equities research analysts have issued 1 year price objectives for Intuitive Surgical's shares. Their predictions range from $675.00 to $1,050.00. On average, they anticipate Intuitive Surgical's stock price to reach $924.80 in the next twelve months. View Analyst Ratings for Intuitive Surgical.

What are analysts saying about Intuitive Surgical stock?

Here are some recent quotes from research analysts about Intuitive Surgical stock:

  • 1. Cantor Fitzgerald analysts commented, "Procedure growth: Guidance for 2017 procedure growth appears to be conservative. ISRG had 17% procedure growth in the 1H and is guiding to 14-15% procedure growth for 2017, implying 11-13% procedure growth in the 2H. The first-half procedure growth came in above expectations, as gynecology (grew in low single digits) and urology (grew in mid-to-high single digits) and China (grew by well over 25%) outpaced expectations. Second-half guidance assumes slower growth in gynecology, urology, and China, one less selling day in 3Q, and lower growth in Japan due to a lack of reimbursement." (7/21/2017)
  • 2. According to Zacks Investment Research, "Over the last three months, Intuitive Surgical was trading consistently ahead of the broader industry. While a stellar first-quarter 2017 result was a major market sentiment booster, the company gained significantly on the CE Mark approval for da Vinci X in Europe. The stock has got a further boost on the recent U.S. FDA approval of the same. A positive outlook for the coming quarters also raises our confidence in the stock. Further, incremental spending on product development and higher investments in international markets are prudent moves that are likely to drive long-term growth. The company is also expected to enhance its organizational capabilities and gain prominence in the markets of Europe and Asia. However, the da Vinci Surgical System has a long sale and purchase order cycle which might act against the company. In fact, the stock looks a tad expensive, adding to our concerns." (6/20/2017)

Who are some of Intuitive Surgical's key competitors?

Who are Intuitive Surgical's key executives?

Intuitive Surgical's management team includes the folowing people:

  • Lonnie M. Smith, Independent Chairman of the Board
  • Gary S. Guthart Ph.D., President, Chief Executive Officer, Director
  • Marshall L. Mohr, Chief Financial Officer, Senior Vice President
  • Salvatore J. Brogna, Executive Vice President - Product Operations
  • David J. Rosa, Executive Vice President, Chief Commercial Officer
  • Mark J. Meltzer, Senior Vice President, Chief Compliance Officer, General Counsel
  • Myriam J. Curet M.D., Senior Vice President, Chief Medical Officer
  • Jamie E. Samath, Vice President, Corporate Controller, and Principal Accounting Officer
  • Alan J. Levy Ph.D., Lead Independent Director
  • Craig H. Barratt Ph.D., Independent Director

Who owns Intuitive Surgical stock?

Intuitive Surgical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Chevy Chase Trust Holdings Inc. (0.16%), Bank of Montreal Can (0.11%), Manning & Napier Advisors LLC (0.11%), Gateway Investment Advisers LLC (0.10%), National Pension Service (0.09%) and APG Asset Management N.V. (0.08%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Eric H Halvorson, Gary S Guthart, George Stalk Jr, Jamie Samath, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr and Salvatore Brogna. View Institutional Ownership Trends for Intuitive Surgical.

Who sold Intuitive Surgical stock? Who is selling Intuitive Surgical stock?

Intuitive Surgical's stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Advisors LLC, Factory Mutual Insurance Co., Gateway Investment Advisers LLC, Exxonmobil Investment Management Inc. TX, Rothschild Investment Corp IL, OLD National Bancorp IN, Quantitative Systematic Strategies LLC and Oregon Public Employees Retirement Fund. Company insiders that have sold Intuitive Surgical stock in the last year include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr and Salvatore Brogna. View Insider Buying and Selling for Intuitive Surgical.

Who bought Intuitive Surgical stock? Who is buying Intuitive Surgical stock?

Intuitive Surgical's stock was bought by a variety of institutional investors in the last quarter, including Mn Services Vermogensbeheer B.V., Bank of Montreal Can, Assenagon Asset Management S.A., National Pension Service, Chevy Chase Trust Holdings Inc., Aperio Group LLC, Deane Retirement Strategies Inc. and State of Alaska Department of Revenue. View Insider Buying and Selling for Intuitive Surgical.

How do I buy Intuitive Surgical stock?

Shares of Intuitive Surgical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intuitive Surgical's stock price today?

One share of Intuitive Surgical stock can currently be purchased for approximately $927.47.

MarketBeat Community Rating for Intuitive Surgical (NASDAQ ISRG)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  446 (Vote Outperform)
Underperform Votes:  376 (Vote Underperform)
Total Votes:  822
MarketBeat's community ratings are surveys of what our community members think about Intuitive Surgical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Intuitive Surgical (NASDAQ:ISRG) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $924.80 (0.29% downside)

Analysts' Ratings History for Intuitive Surgical (NASDAQ:ISRG)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/21/2017J P Morgan Chase & CoReiterated RatingOverweight$1,050.00HighView Rating Details
7/21/2017Barclays PLCBoost Price TargetOverweight$1,000.00HighView Rating Details
7/21/2017Cantor FitzgeraldReiterated RatingHold$1,050.00HighView Rating Details
7/18/2017Royal Bank Of CanadaBoost Price TargetSector Perform -> Sector Perform$800.00 -> $950.00LowView Rating Details
7/12/2017Wells Fargo & CompanyReiterated RatingOutperform$1,000.00 -> $1,050.00LowView Rating Details
7/11/2017Canaccord GenuityReiterated RatingHold$870.00LowView Rating Details
7/5/2017Leerink SwannReiterated RatingOutperformMediumView Rating Details
6/15/2017BTIG ResearchReiterated RatingHoldLowView Rating Details
6/1/2017Bank of America CorporationReiterated RatingBuy$1,000.00LowView Rating Details
5/22/2017Morgan StanleySet Price TargetOverweight$840.00 -> $950.00LowView Rating Details
5/16/2017Goldman Sachs Group, Inc. (The)Initiated CoverageBuy -> Buy$1,000.00MediumView Rating Details
4/25/2017Jefferies Group LLCReiterated RatingBuy$675.00LowView Rating Details
4/24/2017WedbushBoost Price TargetOutperform$835.00 -> $875.00LowView Rating Details
4/22/2017Citigroup Inc.Reiterated RatingBuy$820.00 -> $917.00LowView Rating Details
4/19/2017Stifel NicolausBoost Price TargetBuy$800.00 -> $850.00LowView Rating Details
4/19/2017Evercore ISIBoost Price TargetIn-Line$750.00 -> $785.00LowView Rating Details
8/26/2016Raymond James Financial, Inc.Initiated CoverageOutperformN/AView Rating Details
7/21/2016Northland SecuritiesDowngradeMarket Perform -> Under Perform$600.00N/AView Rating Details
7/20/2016Piper Jaffray CompaniesReiterated RatingNeutral$610.00 -> $700.00N/AView Rating Details
4/14/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
1/22/2016William BlairReiterated RatingBuyN/AView Rating Details
(Data available from 7/22/2015 forward)


Earnings History for Intuitive Surgical (NASDAQ:ISRG)
Earnings by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Earnings History by Quarter for Intuitive Surgical (NASDAQ ISRG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/16/2017$5.93N/AView Earnings Details
7/20/2017Q2 2017$5.79$5.95$724.51 million$756.20 millionViewN/AView Earnings Details
4/18/2017Q1 17$3.97$5.09$664.72 million$674.20 millionViewN/AView Earnings Details
1/24/2017Q416$5.99$6.09$739.65 million$757.00 millionViewN/AView Earnings Details
10/18/2016Q3$5.13$6.19$650.49 million$682.90 millionViewListenView Earnings Details
7/19/2016Q216$4.97$5.62$640.69 million$670.00 millionViewListenView Earnings Details
4/19/2016Q1$4.33$4.42$593.08 million$594.50 millionViewListenView Earnings Details
1/21/2016Q4$5.04$5.89$655.32 million$676.50 millionViewListenView Earnings Details
10/20/2015Q3$4.23$5.24$580.37 million$590.00 millionViewListenView Earnings Details
7/21/2015Q2$3.98$4.57$566.86 million$586.10 millionViewListenView Earnings Details
4/21/2015Q1$2.85$3.57$535.10 million$532.10 millionViewListenView Earnings Details
1/22/2015Q4$3.43$4.18$599.17 million$604.70 millionViewListenView Earnings Details
10/21/2014Q314$2.68$3.92$515.44 million$550.00 millionViewListenView Earnings Details
7/22/2014Q214$2.76$2.77$502.23 million$512.00 millionViewListenView Earnings Details
4/22/2014Q114$3.34$2.67$507.04 million$464.70 millionViewListenView Earnings Details
1/23/2014Q413$3.81$4.28$576.00 million$576.20 millionViewListenView Earnings Details
10/17/2013Q313$3.40$3.99$525.47 million$499.00 millionViewListenView Earnings Details
7/18/2013Q2 2013$4.04$3.90$594.58 million$578.50 millionViewListenView Earnings Details
4/18/2013Q1 2013$4.02$4.56$583.59 million$611.40 millionViewListenView Earnings Details
1/22/2013Q4 2012$4.02$4.25$584.36 million$609.30 millionViewListenView Earnings Details
10/16/2012$3.51$4.46ViewN/AView Earnings Details
7/19/2012$3.57$3.75ViewN/AView Earnings Details
4/17/2012$3.15$3.50ViewN/AView Earnings Details
1/19/2012$3.35$3.75ViewN/AView Earnings Details
10/18/2011$2.81$3.05ViewN/AView Earnings Details
7/19/2011$2.71$2.91ViewN/AView Earnings Details
4/19/2011$2.49$2.59ViewN/AView Earnings Details
1/20/2011$2.25$3.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Intuitive Surgical (NASDAQ:ISRG)
2017 EPS Consensus Estimate: $19.08
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$3.96$3.96$3.96
Q2 20171$4.55$4.55$4.55
Q3 20171$4.89$4.89$4.89
Q4 20171$5.68$5.68$5.68
(Data provided by Zacks Investment Research)


Dividend History for Intuitive Surgical (NASDAQ:ISRG)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Intuitive Surgical (NASDAQ:ISRG)
Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 97.53%
Insider Trades by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Insider Trades by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/12/2017Mark J MeltzerSVPSell3,000$887.09$2,661,270.00View SEC Filing  
6/8/2017Mark J RubashDirectorSell3,000$931.51$2,794,530.00View SEC Filing  
6/7/2017Curet MyriamSVPSell750$930.00$697,500.00View SEC Filing  
6/5/2017Curet MyriamSVPSell2,644$921.26$2,435,811.44View SEC Filing  
6/5/2017Jamie SamathVPSell1,946$921.26$1,792,771.96View SEC Filing  
6/1/2017Salvatore BrognaEVPSell1,306$915.09$1,195,107.54View SEC Filing  
5/31/2017Amal M JohnsonDirectorSell1,000$917.27$917,270.00View SEC Filing  
5/5/2017Jamie SamathVPSell48$850.00$40,800.00View SEC Filing  
5/2/2017Curet MyriamSVPSell3,385$837.21$2,833,955.85View SEC Filing  
4/27/2017Marshall MohrCFOSell8,950$835.89$7,481,215.50View SEC Filing  
4/25/2017Jamie SamathVPSell626$825.00$516,450.00View SEC Filing  
4/24/2017Alan J LevyDirectorSell1,386$813.15$1,127,025.90View SEC Filing  
4/21/2017David J. RosaEVPSell5,000$810.52$4,052,600.00View SEC Filing  
4/21/2017Gary S GuthartCEOSell18,775$810.33$15,213,945.75View SEC Filing  
4/21/2017Jamie SamathVPSell490$811.67$397,718.30View SEC Filing  
4/21/2017Lonnie M SmithDirectorSell3,000$810.12$2,430,360.00View SEC Filing  
3/15/2017Amal M JohnsonDirectorSell1,000$750.00$750,000.00View SEC Filing  
3/15/2017David J RosaEVPSell5,000$750.00$3,750,000.00View SEC Filing  
3/15/2017Jamie SamathVPSell4,268$750.00$3,201,000.00View SEC Filing  
3/15/2017Marshall MohrCFOSell4,250$750.00$3,187,500.00View SEC Filing  
3/1/2017Salvatore BrognaEVPSell6,628$736.80$4,883,510.40View SEC Filing  
2/24/2017Curet MyriamSVPSell222$729.80$162,015.60View SEC Filing  
2/21/2017Mark J MeltzerSVPSell8,750$724.82$6,342,175.00View SEC Filing  
2/7/2017Colin MoralesSVPSell1,000$703.99$703,990.00View SEC Filing  
2/2/2017Marshall MohrCFOSell2,000$700.00$1,400,000.00View SEC Filing  
1/27/2017Lonnie M SmithDirectorSell1,000$684.38$684,380.00View SEC Filing  
12/13/2016David J RosaEVPSell7,200$650.00$4,680,000.00View SEC Filing  
12/13/2016Lonnie M SmithDirectorSell1,000$650.00$650,000.00View SEC Filing  
11/17/2016Lonnie M SmithDirectorSell275$646.50$177,787.50View SEC Filing  
11/7/2016Gary S GuthartCEOSell13,515$680.68$9,199,390.20View SEC Filing  
8/22/2016Mark J MeltzerSVPSell3,000$688.33$2,064,990.00View SEC Filing  
8/4/2016Alan J LevyDirectorSell3,188$694.11$2,212,822.68View SEC Filing  
8/1/2016Gary S GuthartCEOSell13,400$698.00$9,353,200.00View SEC Filing  
7/27/2016Curet MyriamSVPSell4,250$684.39$2,908,657.50View SEC Filing  
7/27/2016Marshall MohrCFOSell5,000$684.09$3,420,450.00View SEC Filing  
6/2/2016Salvatore BrognaEVPSell600$630.96$378,576.00View SEC Filing  
6/1/2016Salvatore BrognaEVPSell20,406$632.66$12,910,059.96View SEC Filing  
5/17/2016Curet MyriamSVPSell530$629.36$333,560.80View SEC Filing  
5/17/2016Lonnie M SmithDirectorSell2,000$627.23$1,254,460.00View SEC Filing  
5/3/2016George Stalk JrDirectorSell7,644$618.70$4,729,342.80View SEC Filing  
5/2/2016Marshall MohrCFOSell5,000$631.63$3,158,150.00View SEC Filing  
4/27/2016Mark J MeltzerSVPSell16,625$631.52$10,499,020.00View SEC Filing  
4/26/2016Alan J LevyDirectorSell542$631.72$342,392.24View SEC Filing  
4/25/2016Amal M JohnsonDirectorSell2,500$640.00$1,600,000.00View SEC Filing  
4/22/2016Curet MyriamSVPSell8,173$637.75$5,212,330.75View SEC Filing  
4/22/2016Eric H HalvorsonDirectorSell5,688$639.21$3,635,826.48View SEC Filing  
3/14/2016Eric H HalvorsonDirectorSell4,438$593.16$2,632,444.08View SEC Filing  
3/14/2016Mark J MeltzerSVPSell12,500$589.00$7,362,500.00View SEC Filing  
3/11/2016Curet MyriamSVPSell2,000$582.50$1,165,000.00View SEC Filing  
3/11/2016Jamie SamathVPSell8,026$575.95$4,622,574.70View SEC Filing  
3/10/2016Alan J LevyDirectorSell5,000$569.14$2,845,700.00View SEC Filing  
3/7/2016Colin MoralesSVPSell2,500$575.00$1,437,500.00View SEC Filing  
3/4/2016Colin MoralesSVPSell884$571.49$505,197.16View SEC Filing  
3/3/2016Marshall MohrCFOSell2,500$575.00$1,437,500.00View SEC Filing  
3/2/2016Salvatore BrognaEVPSell1,882$567.37$1,067,790.34View SEC Filing  
2/19/2016Colin MoralesSVPSell5,530$542.83$3,001,849.90View SEC Filing  
2/4/2016Curet MyriamSVPSell2,000$551.00$1,102,000.00View SEC Filing  
2/4/2016Marshall MohrCFOSell2,500$550.00$1,375,000.00View SEC Filing  
1/29/2016Mark J. MeltzerSVPSell4,125$527.59$2,176,308.75View SEC Filing  
12/14/2015Salvatore BrognaEVPSell2,734$530.00$1,449,020.00View SEC Filing  
11/20/2015Mark J. MeltzerSVPSell1,625$515.00$836,875.00View SEC Filing  
10/26/2015Mark J. MeltzerSVPSell2,500$498.37$1,245,925.00View SEC Filing  
10/23/2015Lonnie M. SmithDirectorSell10,328$500.00$5,164,000.00View SEC Filing  
9/1/2015Salvatore BrognaEVPSell374$501.99$187,744.26View SEC Filing  
8/18/2015George Stalk JrDirectorSell4,726$532.03$2,514,373.78View SEC Filing  
7/27/2015Gary S GuthartCEOSell17,255$541.98$9,351,864.90View SEC Filing  
7/27/2015Mark J MeltzerSVPSell4,750$542.03$2,574,642.50View SEC Filing  
7/24/2015David J RosaEVPSell2,800$550.20$1,540,560.00View SEC Filing  
7/24/2015Jamie SamathVPSell5,000$550.00$2,750,000.00View SEC Filing  
7/24/2015Lonnie M SmithDirectorSell20,000$544.62$10,892,400.00View SEC Filing  
6/9/2015Alan J LevyDirectorSell417$495.41$206,585.97View SEC Filing  
6/8/2015Gary S GuthartCEOSell17,840$492.16$8,780,134.40View SEC Filing  
5/29/2015Lonnie M SmithDirectorSell2,000$488.68$977,360.00View SEC Filing  
5/27/2015Curet MyriamSVPSell1,000$489.35$489,350.00View SEC Filing  
5/18/2015Colin MoralesSVPSell13,824$503.29$6,957,480.96View SEC Filing  
4/28/2015Curet MyriamSVPSell261$504.54$131,684.94View SEC Filing  
4/27/2015Jerome J McnamaraEVPSell15,000$504.06$7,560,900.00View SEC Filing  
4/27/2015Marshall MohrCFOSell10,000$504.08$5,040,800.00View SEC Filing  
4/24/2015Lonnie M SmithDirectorSell20,000$508.03$10,160,600.00View SEC Filing  
3/2/2015Salvatore BrognaSVPSell1,375$500.98$688,847.50View SEC Filing  
2/6/2015Mark J RubashDirectorSell5,000$520.00$2,600,000.00View SEC Filing  
1/27/2015Jerome J McnamaraEVPSell15,000$511.32$7,669,800.00View SEC Filing  
1/27/2015Lonnie M SmithDirectorSell20,000$511.31$10,226,200.00View SEC Filing  
1/27/2015Marshall MohrCFOSell5,000$511.14$2,555,700.00View SEC Filing  
12/8/2014Lonnie M SmithDirectorSell1,700$511.24$869,108.00View SEC Filing  
12/1/2014Salvatore BrognaSVPSell1,375$515.87$709,321.25View SEC Filing  
11/24/2014Colin MoralesSVPSell9,565$520.82$4,981,643.30View SEC Filing  
10/31/2014Marshall MohrCFOSell7,500$500.00$3,750,000.00View SEC Filing  
10/30/2014Floyd D Md LoopDirectorSell2,125$488.95$1,039,018.75View SEC Filing  
10/27/2014Floyd D Md LoopDirectorSell15,209$475.71$7,235,073.39View SEC Filing  
10/27/2014Jerome J McnamaraEVPSell15,000$473.76$7,106,400.00View SEC Filing  
10/27/2014Marshall MohrCFOSell2,500$473.50$1,183,750.00View SEC Filing  
9/2/2014Salvatore BrognaSVPSell12,626$472.06$5,960,229.56View SEC Filing  
8/26/2014Colin MoralesSVPSell4,105$478.66$1,964,899.30View SEC Filing  
7/28/2014Jerome J McnamaraEVPSell9,167$465.59$4,268,063.53View SEC Filing  
7/25/2014Colin MoralesSVPSell2,000$461.99$923,980.00View SEC Filing  
2/27/2014Colin MoralesSVPSell1,000$445.00$445,000.00View SEC Filing  
12/3/2012Lonnie M SmithChairmanSell1,000$525.98$525,980.00View SEC Filing  
9/4/2012Salvatore BrognaSVPSell1,250$490.25$612,812.50View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Intuitive Surgical (NASDAQ:ISRG)
Latest Headlines for Intuitive Surgical (NASDAQ:ISRG)
DateHeadline logoTop Analyst Lifts Price Target for Intuitive Surgical, Inc. (ISRG) on Back of Strong 2Q Results - July 22 at 2:19 AM logoCan Intuitive Surgical Hit $1,000? - July 22 at 2:19 AM logoThis Robotics Player Neared 1,000, Then Toppled — Here's Why - July 22 at 2:18 AM logoIntuitive Surgical, Inc. Slow Earnings Growth Masks Deeper Strength - July 21 at 2:30 PM logoNo Reason To Believe Intuitive Surgical's Momentum Will Stop Now - July 21 at 11:49 AM logoIntuitive Surgical, Inc. (NASDAQ:ISRG) Given Overweight Rating at J P Morgan Chase & Co - July 21 at 7:52 AM logoBRIEF-Intuitive Surgical announces Q2 GAAP earnings per share $5.77 - July 21 at 5:05 AM logoEarnings Reaction History: Intuitive Surgical Inc, 66.7% Follow-Through Indicator, 5.8% Sensitive - July 21 at 5:05 AM logoIntuitive Surgical Inc. Profit Rises 4% In Q2 - July 21 at 5:05 AM logoInvestor Network: Intuitive Surgical, Inc. to Host Earnings Call - July 21 at 5:05 AM logoIntuitive Surgical Announces Second Quarter Earnings - July 21 at 5:05 AM logoIntuitive Surgical second-quarter net profit rises 20 percent - July 21 at 5:05 AM logoEdited Transcript of ISRG earnings conference call or presentation 20-Jul-17 8:30pm GMT - July 21 at 5:05 AM logoIntuitive Surgical, Inc. (NASDAQ:ISRG) Rating Lowered to Hold at Vetr Inc. - July 21 at 12:44 AM logoIntuitive Surgical Reports New Employee Option Grants for July 2017 - GlobeNewswire (press release) - July 21 at 12:04 AM logoIntuitive Surgical, Inc. in 3 Charts - Motley Fool - July 21 at 12:04 AM logoIntuitive Surgical tops Street 2Q forecasts - July 21 at 12:04 AM logoIntuitive Surgical profit beats Wall Street estimates - July 21 at 12:04 AM logoIntuitive Surgical, Inc. (ISRG) Posts Earnings Results, Beats Estimates By $0.16 EPS - July 20 at 9:04 PM logoIntuitive Surgical Q2 top line up 13%; earnings up 20%; shares up 1% after hours - July 20 at 4:53 PM logo12 Stocks To Watch For July 20, 2017 - Benzinga - July 20 at 6:53 AM logoIntuitive Surgical, Inc. in 3 Charts - July 19 at 10:26 PM logoHow Intuitive Surgical Is Returning Value to Its Shareholders - July 19 at 7:14 AM logoWill Intuitive Surgical (ISRG) Surprise in Q2 Earnings? - July 19 at 7:14 AM logoWhether Up or Down in After-Hours, Intuitive Surgical Adds to ... - Nasdaq - July 18 at 4:53 PM logoWill Intuitive Surgical (ISRG) Surprise in Q2 Earnings? - Nasdaq - July 18 at 4:53 PM logoIntuitive Surgical Reports New Employee Option Grants for July 2017 - July 18 at 4:53 PM logoIntuitive Surgical, Inc. (ISRG) Receives Consensus Recommendation of "Buy" from Brokerages - July 18 at 2:45 PM logoWhat to Expect from Intuitive Surgical’s 2Q17 Earnings - July 17 at 8:15 AM logoWhat Wall Street Analysts Recommend for Intuitive Surgical - July 16 at 12:08 PM logoNotable Friday Option Activity: WMT, ISRG, UA - Nasdaq - July 15 at 2:36 AM logoIntuitive Surgical, Inc. (NASDAQ:ISRG) Scheduled to Post Earnings on Thursday - July 13 at 10:08 PM logoIntuitive Surgical, Inc. (NASDAQ:ISRG) Rating Reiterated by Wells Fargo & Company - July 12 at 10:36 AM logo$722.14 Million in Sales Expected for Intuitive Surgical, Inc. (NASDAQ:ISRG) This Quarter - July 12 at 9:51 AM logo$4.86 Earnings Per Share Expected for Intuitive Surgical, Inc. (NASDAQ:ISRG) This Quarter - July 10 at 6:22 PM logoIntuitive Surgical, Inc. (NASDAQ:ISRG) Receives Outperform Rating from Leerink Swann - July 9 at 9:04 PM logoNotable Thursday Option Activity: DIS, ISRG, YUMC - Nasdaq - July 7 at 6:35 AM logoWith Increasing Conviction In Intuitive Surgical, Analyst Sees 17% Upside From Here - Benzinga - July 7 at 6:35 AM logoWith Increasing Conviction In Intuitive Surgical, Analyst Sees 17% Upside From Here - July 6 at 6:44 AM logoIntuitive Surgical, Inc. (ISRG) Earns Neutral Rating from Analysts at Cantor Fitzgerald - June 29 at 6:02 PM logoDMC Global Inc. (BOOM) Ex-Dividend Date Scheduled for June 28, 2017 - Nasdaq - June 27 at 11:13 PM logoUnderstanding Competitive Threats For Intuitive Surgical - June 26 at 7:50 PM logoIntuitive Surgical, Inc. (ISRG) Upgraded to "Strong-Buy" at BidaskClub - June 23 at 8:20 PM logoWill Intuitive Surgical Stock Witness Continued Growth Momentum? - June 23 at 6:19 PM logoWhat Analysts Recommend for Intuitive Surgical - June 23 at 6:19 PM logoISRG Expands across Low-Cost Markets with Da Vinci X Launch - June 23 at 6:19 PM logoDa Vinci Sp Could Boost ISRG Stock - June 23 at 6:19 PM logoIntuitive Surgical, Inc. (ISRG) Given Average Recommendation of "Buy" by Analysts - June 23 at 12:34 PM logoS&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017 - June 21 at 3:42 PM logoIntuitive Surgical Rises As Rivals Fail To Crack DaVinci Code - June 20 at 6:55 PM



Intuitive Surgical (ISRG) Chart for Saturday, July, 22, 2017

This page was last updated on 7/22/2017 by Staff